Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Broggini

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|January 7, 2025
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoringMichele Tomanelli, Federica Guffanti, Giulia Vargiu, et al.
Frontiers in Oncology|June 1, 2022
LKB1: Can We Target an Hidden Target? Focus on NSCLCGloriana Ndembe, Ilenia Intini, Elisa Perin, et al.
Cancer Biology & Therapy|June 25, 2013
Non-hepatic tumors change the activity of genes encoding copper trafficking proteins in the liverPolina S Babich, Alexey N Skvortsov, Paolo Rusconi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 22, 2014
Brassinin and its derivatives as potential anticancer agentsMartina Chripkova, David Drutovic, Martina Pilatova, et al.
American Journal of Cancer Research|April 18, 2013
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patientsFrancesca Ricci, Sergio Bernasconi, Luca Porcu, et al.
Gynecologic Oncology|May 11, 2010
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenograftsSara Previdi, Anastasia Malek, Veronica Albertini, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 11, 2014
Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cellsDavid Drutovic, Martina Chripkova, Martina Pilatova, et al.
Cancer Research|April 17, 2002
Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathioneCristina Geroni, Sergio Marchini, Paolo Cozzi, et al.
Scientific Reports|December 15, 2016
The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugsEliana Rulli, Federica Guffanti, Elisa Caiola, et al.
The International Journal of Biological Markers|May 19, 2015
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 functionUgo De Giorgi, Juping Yuan, Mauro Moroni, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|January 7, 2025
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoringMichele Tomanelli, Federica Guffanti, Giulia Vargiu, et al.
Frontiers in Oncology|June 1, 2022
LKB1: Can We Target an Hidden Target? Focus on NSCLCGloriana Ndembe, Ilenia Intini, Elisa Perin, et al.
Cancer Biology & Therapy|June 25, 2013
Non-hepatic tumors change the activity of genes encoding copper trafficking proteins in the liverPolina S Babich, Alexey N Skvortsov, Paolo Rusconi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 22, 2014
Brassinin and its derivatives as potential anticancer agentsMartina Chripkova, David Drutovic, Martina Pilatova, et al.
American Journal of Cancer Research|April 18, 2013
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patientsFrancesca Ricci, Sergio Bernasconi, Luca Porcu, et al.
Gynecologic Oncology|May 11, 2010
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenograftsSara Previdi, Anastasia Malek, Veronica Albertini, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 11, 2014
Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cellsDavid Drutovic, Martina Chripkova, Martina Pilatova, et al.
Cancer Research|April 17, 2002
Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathioneCristina Geroni, Sergio Marchini, Paolo Cozzi, et al.
Scientific Reports|December 15, 2016
The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugsEliana Rulli, Federica Guffanti, Elisa Caiola, et al.
The International Journal of Biological Markers|May 19, 2015
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 functionUgo De Giorgi, Juping Yuan, Mauro Moroni, et al.
Pageof 12